SMB Technology: Optimizing API Purification

Explore how Simulated Moving Bed (SMB) technology can enhance API production while overcoming common misconceptions about chromatographic purification.

ADC Payload-Linker Services

Explore how advanced high-potency capabilities and specialized expertise are driving the development and manufacturing of next-generation ADC payloads and linkers.

Simulated Bed Chromatography Advantages

Discover how Simulated Moving Bed (SMB) technology can revolutionize your purification processes by enhancing efficiency, reducing costs, and promoting sustainable practices.

SK pharmteco Capacity Update April 2025: Small Molecule

Join Nicholas Duda, Executive Director of Business Development, as he highlights our available capacity across North America, Europe, and Asia, and our unique capabilities.

SK pharmteco Capacity Update April 2025: Analytical Services

Get the quality, compliance, and accelerated development support you need for your small molecule and cell and gene therapy program with our advanced analytical testing services.

SK pharmteco's Texas Facility: A Pillar Of Innovation, Sustainability, And Pharmaceutical Excellence

Discover how SK pharmteco's innovative La Porte, Texas facility combines advanced technology, sustainability, and strategic efficiency to redefine excellence in pharmaceutical manufacturing.

Energetic And Specialty Chemistry Solutions

Partner with SK pharmteco to harness decades of expertise in safe, scalable, and reliable production of APIs using advanced energetic chemistry, delivering exceptional value from development to commercialization.

Demystifying Large Scale Continuous Chromatography For Small Molecules

Learn the fundamentals of developing a continuous chromatography process with Simulated Moving Bed (SMB) technology for small molecules, from gram-scale to multi-ton commercial production.

Continuous Flow Processing: A Sustainable Manufacturing Solution

Optimize your manufacturing processes and enhance sustainability, while meeting regulatory requirements and minimizing environmental impact.

Third Principle Of Green Chemistry: Less Hazardous Chemical Syntheses

Chemists and chemical engineers must prioritize sustainable practices by innovating holistic, efficient processes that minimize environmental impact and toxicity, addressing challenges like solvent waste and complex molecule synthesis.

Adapting A rcAAV Assay For Commercial Manufacturing

Witness how to implement sensitive, cell-based qPCR assays to reliably detect rcAAVs and safeguard the integrity of your rAAV gene therapy manufacturing process.

Pioneering Plasmid-IQ Design

Gain insights into the significance of plasmid design in viral vector production and the use of analytical assays and Next-Generation Sequencing for plasmid verification.

SK pharmteco Capacity Update April 2025: Cell & Gene Therapy

Our integrated expertise — from plasmid science to viral vector and cell therapy manufacturing — can accelerate and de-risk the development of your advanced therapies.

SK pharmteco Capacity Update April 2025: Analytical Services

Get the quality, compliance, and accelerated development support you need for your small molecule and cell and gene therapy program with our advanced analytical testing services.

Revolutionizing Plasmid Design With Trusted Expertise

Optimize your plasmid design to enhance performance, simplify scale-up, and meet your development goals with confidence.

Overcoming Plasmid Design Challenges With Expert Support

Learn how strategic plasmid design and specialized consulting services can help overcome engineering challenges and accelerate therapeutic innovation.

Transforming Viral Vector Manufacturing With Next-Generation CGMP Plasmids Platform

Watch as experts explore key innovations in plasmid design and production, highlighting how these advancements can directly enhance biomanufacturing workflows.

CGMP-Validated RCL Assay Used For Release Testing Of Manufactured Viruses, Gene Mediated Cell Therapy Products

Ensure the safety and efficacy of lentiviral-based therapies by addressing the risks of replication-competent lentiviruses (RCLs) through advanced monitoring and control strategies.

cGMP-Ready Clonal HEK293 Cell Line For AAV, Lentiviral, And Adenoviral Vector Production

See how this advanced SKPT-HEK293 4G9 was able to provide a robust, CGMP-ready solution for efficient viral vector production, supporting a range of AAV serotypes and CAR-T Lenti-viral vectors for scalable manufacturing.

SK pharmteco Capacity Update October 2024: Cell & Gene Therapy

Check out our enhanced capacity and expertise in supporting CGT projects, offering end-to-end solutions from viral vector and plasmid development to GMP manufacturing and regulatory support.

Control Strategies And Method Development For Nitrosamines In APIs And Drug Products

Explore regulatory insights, analytical strategies, and real-world case studies for effective nitrosamine control in APIs and drug products.

Sequencing Solutions For Nucleic Acids And Advanced Therapy Products

Leveraging an experienced partner's expertise in GMP-grade plasmid manufacturing and advanced analytical methods can accelerate the development and success of your next-generation therapies.

Inspiring Waves Of Change

Our comprehensive capabilities include the production of Active Pharmaceutical Ingredients (APIs), advanced intermediates, Cell and Gene Therapy technologies, registered starting materials, and analytical services.

Shedding Light On Photostability Forced Degradation

Ensure the stability and safety of your drug products by utilizing comprehensive forced degradation and photo-stability testing, guided by ICH and FDA standards, to identify degradation pathways and assess light exposure risks.

Stability And Storage Supported By Expert Scientists

Partner with SK pharmteco for reliable, ICH-compliant stability testing and storage solutions, supported by expert scientists and fully qualified chambers to ensure the safety and efficacy of your CGMP products.

Energy And Specialty Chemistry Solutions

Safely scale the production of APIs using highly energetic chemistry, backed by decades of expertise, controlled processes, and CGMP-compliant conditions from development to commercial manufacturing.

Stability And Storage Testing

Receive comprehensive stability testing solutions that ensure the safety, efficacy, and quality of your pharmaceutical products at every stage of development by partnering with us.

Nitrosamine Impurity And Control Testing

Get access to reliable testing services for the identification and quantification of impurities, ensuring product quality and maintaining patient confidence.

Control Strategies And Method Development For Nitrosamines In Peptide APIs And Drug Products

Pharmaceutical scientists and engineers must advance robust, sensitive, and efficient nitrosamine detection and control methods to ensure regulatory compliance and safeguard public health in peptide-based drugs.

Control Strategies And Method Development For Nitrosamines In APIs, Drug Products

Gain critical insights into nitrosamine control strategies, regulatory requirements, and advanced analytical methods to ensure compliance by August 2025.